Factors associated with variation in hospital use at the End of Life in England

Similar documents
Exploring the cost of care at the end of life

Effect of the British Red Cross Support at Home service on hospital utilisation

Use of social care data for impact analysis and risk stratification

London CCG Neurology Profile

Scottish Hospital Standardised Mortality Ratio (HSMR)

Outcomes benchmarking support packs: CCG level

Person-based Resource Allocation

Results of censuses of Independent Hospices & NHS Palliative Care Providers

Understanding patterns of health and social care at the end of life

DATA Briefing. Emergency hospital admissions for ambulatory care-sensitive conditions: identifying the potential for reductions.

Briefing: The impact of providing enhanced support for care home residents in Rushcliffe

O U T C O M E. record-based. measures HOSPITAL RE-ADMISSION RATES: APPROACH TO DIAGNOSIS-BASED MEASURES FULL REPORT

Focus on hip fracture: Trends in emergency admissions for fractured neck of femur, 2001 to 2011

NHS performance statistics

National Hospice and Palliative Care OrganizatioN. Facts AND Figures. Hospice Care in America. NHPCO Facts & Figures edition

National Survey of Patient Activity Data for Specialist Palliative Care Services MDS Full Report for the year

Do quality improvements in primary care reduce secondary care costs?

Ambulatory emergency care Reimbursement under the national tariff

NHS Performance Statistics

Key facts and trends in acute care

NHS Wiltshire PCT Programme Budgeting fact sheet /12 Contents

Understanding patient pathways and the impact of emergency admissions in MS & Parkinson s disease

End of Life Care. LONDON: The Stationery Office Ordered by the House of Commons to be printed on 24 November 2008

WHY OFFER SAME DAY DISCHARGE FOR NON-RECONSTRUCTIVE BREAST CANCER SURGERY?

NHS performance statistics

Operational Focus: Performance

Is the quality of care in England getting better? QualityWatch Annual Statement 2013: Summary of findings

3. Q: What are the care programmes and diagnostic groups used in the new Formula?

National Schedule of Reference Costs data: Community Care Services

Improving Quality of Life of Long-Term Patient - From the Community Perspective

Executive Summary 10 th September Dr. Richard Wagland. Dr. Mike Bracher. Dr. Ana Ibanez Esqueda. Professor Penny Schofield

NCPC Specialist Palliative Care Workforce Survey. SPC Longitudinal Survey of English Cancer Networks

21 March NHS Providers ON THE DAY BRIEFING Page 1

Commissioning for Value: Integrated care pathways

SUMMARY. Our progress in 2013/14. Eastbourne, Hailsham and Seaford Clinical Commissioning Group.

Integrated Intelligence and system modelling in Kent

Findings from the Balance of Care / Continuing Care Census

Vertical integration: who should join up primary and secondary care?

Coordinated cancer care: better for patients, more efficient. Background

A new integrated model for Care Homes from Walsall CCG/Healthcare NHS Trust

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9

Suffolk Health and Care Review

The non-executive director s guide to NHS data Part one: Hospital activity, data sets and performance

Improving choice at end of life

Newton Abbot Locality Development

THE VIRTUAL WARD MANAGING THE CARE OF PATIENTS WITH CHRONIC (LONG-TERM) CONDITIONS IN THE COMMUNITY

Statistical methods developed for the National Hip Fracture Database annual report, 2014

National Cancer Patient Experience Survey National Results Summary

Monthly and Quarterly Activity Returns Statistics Consultation

The PCT Guide to Applying the 10 High Impact Changes

The state of health care and adult social care in England. An overview of key themes in care in 2011/12

NUTRITION SCREENING SURVEYS IN HOSPITALS IN NORTHERN IRELAND,

Emergency readmission rates

NWL STP plans for the last phase of life

Comparison of mode of access to GP telephone consultation and effect on A&E usage

London Councils: Diabetes Integrated Care Research

National Cancer Patient Experience Survey National Results Summary

NEW MODELS OF CARE AND THE PREVENTION AGENDA: AN INTEGRAL PARTNERSHIP CHAIR: ROB WEBSTER, CHIEF EXECUTIVE, NHS CONFEDERATION

Reference costs 2016/17: highlights, analysis and introduction to the data

The Art of the Possible Telemedicine in Health Care

My Discharge a proactive case management for discharging patients with dementia

City and Hackney Clinical Commissioning Group Prospectus May 2013

NHS Dorset Clinical Commissioning Group Governing Body Meeting Financial Position as at 31 st July C Hickson, Head of Management Accounts

HC 491 SesSIon december Department of Health. Management of NHS hospital productivity

Indicator Specification:

Increased mortality associated with week-end hospital admission: a case for expanded seven-day services?

The Royal Wolverhampton Hospitals NHS Trust

Findings from the 6 th Balance of Care / Continuing Care Census

Building Partnerships and Reducing Demand through Telemedicine

April Clinical Governance Corporate Report Narrative

2017/18 and 2018/19 National Tariff Payment System Annex E: Guidance on currencies without national prices. NHS England and NHS Improvement

WAITING TIMES 1. PURPOSE

time to replace adjusted discharges

New Facts and Figures on Hospice Care in America

Collaboration & Prevention Exploring new models of care in tertiary mental health. Colin Martin Chief Executive

ew methods for forecasting bed requirements, admissions, GP referrals and associated growth

Introducing the care.data programme

Paediatric Critical Care and Specialised Surgery in Children Review. Paediatric critical care and ECMO: interim update

Practice based commissioning in the NHS: the implications for mental health

Commissioning and statutory funding arrangements for hospice and palliative care providers in England 2017

Night, weekend and bank holiday Specialist Palliative Care Services

Community Care Statistics : Referrals, Assessments and Packages of Care for Adults, England

Mental Health Crisis Pathway Analysis

Commentary for East Sussex

Marginal Rate Emergency Threshold. Executive Summary

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES Service Specifications

Emergency admissions to hospital: managing the demand

Strategic KPI Report Performance to December 2017

Primary medical care new workload formula for allocations to CCG areas

Hospital Generated Inter-Speciality Referral Policy Supporting people in Dorset to lead healthier lives

Unscheduled care Urgent and Emergency Care

Developing a new approach to Palliative Care Funding- Final Report 2015/16 Testing

Statistical Analysis Plan

Objectives 2/23/2011. Crossing Paths Intersection of Risk Adjustment and Coding

FINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NHS NATIONAL SERVICES SCOTLAND

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE TRUST BOARD HELD ON 18 NOVEMBER 2015

Johns Hopkins Bloomberg School of Public Health. To be presented at The Predictive Modeling Summit Washington, DC, November 14, 2014

ICRC Extended Study Hall Call Series: An Update on Using Medicare Data to Integrate Care for Medicare-Medicaid Enrollees

Appendix. We used matched-pair cluster-randomization to assign the. twenty-eight towns to intervention and control. Each cluster,

Transcription:

Factors associated with variation in hospital use at the End of Life in England Martin Bardsley,Theo Georghiou, John Billings Nuffield Trust

Aims Explore recent work undertaken by the Nuffield Trust 1. A study documenting relative costs of different health and social care services in the final 90 days of life. 2. A study of variations in hospital use in the last 12 months of life examining the relative importance of person level verses system level factors. 3. An examination of differences in hospital use at the end of life associated with ethnic group. Our work looks at service use and estimated cost specifically at end of life important for planning, managing resources

The Nuffield Trust Promote independent analysis and informed debate on healthcare policy across the UK Charitable organization founded in 1940 Formerly a grant-giving organization Since 2008 we have been conducting in-house research and policy analysis Significant interest in uses of predictive risk techniques William Morris 1st Viscount Nuffield (1877-1963)

Nuffield Trust Research team data linkage projects nuffield trust Combined predictive model nuffield trust Predicting social care costs Predictive risk modelling Resource allocation nuffield trust Risk sharing for CCGs nuffield trust Person based resource allocation nuffield trust Social care at end of life nuffield trust Cancer and social care Descriptive studies Evaluations nuffield trust Integrated care pilots nuffield trust Virtual Wards nuffield trust WSD nuffield trust Marie Curie Nursing Service

Exploiting person level data Linking data a. over time to look at what happens to people not just events b. across care providers to build broader picture Person level Capture services provided ->costs; quality Descriptions of health -> outcomes

Information flows

Pseudonymisation using encrypted NHS numbers

Health and social care event timeline for one person entering intensive social care.

Estimated costs per decedent, Hospital and social care: Change in costs per decedent during final year 2,500 2,000 1,500 1,000 Hospital costs Social care costs 500 12 11 10 9 8 7 6 5 Month prior to death 4 3 2 1 0

Estimating costs across sectors of care at end of life

Emergency admissions for cases where nursing started 8-14 days before death

Impact of MCNS care on hospital costs Table 1 Post index date hospital costs for Marie Curie cases and matched controls Mean (sd) hospital costs per person Activity Type Marie Curie cases Matched controls Difference Emergency admissions 463 ( 1,758) 1,293 ( 2,531) 830 Elective admissions 106 ( 961) 350 ( 1,736) 244 Outpatient attendances 33 ( 212) 76 ( 340) 43 A&E attendances 9 ( 34) 31 ( 60) 22 All hospital activity 610 ( 2,172) 1,750 ( 3,377) 1,140 Significantly greater reduction in costs among those with no recent history of cancer Also cost reduction much greater for those who started receiving MCNS care earlier ( 2,200 for those >2 weeks before death)

Final 90 day costs multiple care services Reflection on data gathered for multiple uses over several years Summary of what we know from our own work Opportunistic - data often limited, not necessarily intended to be exhaustive Secondary aspect modelling impacts of changes in care patterns at the end of life

Approach to costing Costs are related to commissioner not necessarily the provider or related to local efficiency Uses unit costs (PSSRU mainly) related to a measure of activity eg GP visit, Community nurse contact, social care care days Hospital activity based on tariffs with some especially base estimates for non tariff costs Hospice costs based on advice MCCC and NCPC

Final 90 days Hospital Care 2009/10 2011/12 England wide HES - ONS data Average cost per day, per person N = 1.3M All Care 4,580 Unplanned adms 3,465 Planned adms 822 Outpatients 211 AE 82

Final 90 days Social Care 2007 2010 LA funded care only 7 areas Social care data linked to SUS, and GP register Average cost per month, per person N = 73,243 All Care 1,010 Res/Nurs home Home care Other (~two thirds none)

Final 90 days District nursing 2006-2011 Single London borough Community nursing dataset linked to GP register Average minutes per day, per person N = 10,779 All Care 278 (Average minutes in final 90 days = 214; Two thirds - none)

Final 90 days GP consultations data 2006-2011 Three London PCTs GP dataset Estimated consultations Estimated GP consultations per day N = 21,522 All Care 147 (Average number estimated consultations = 4.6; One third none)

Hospice stays No direct data ONS data to identify rates of people dying in hospices (5.5%) Estimated average LOS of stays in hospice (14 days) Used per diem costs averaging PSSRU, Help the Hospices and Marie Curie estimates to 400 per day Included stays that did not end in death (assume within 90 days) Ended up approx 10,000 per person who died in hospice. Equivalent to about 550 per person who died

Summary cost estimates

Guessing the breakdown of expenditure across the last 90 days of life 2% 8% 4% Emergency inpatient admissions Non-emergency inpatient admissions Outpatient attendances 15% AE visits 1% 3% 53% LA funded social care District nursing care 13% GP visits CAVEAT not the same populations

Observations Scale of costs outside of institutional (hospital/hospice ) care seemed low and not enough to offset potential savings from home based eol care Our approach was pragmatic scratching together what data we could and making some assumptions With more time we could have done this better and we think there needs to be a better understanding of costs for this critical phase of care

What factors are driving variation in hospital care in the last 12 months of life?

Variations in the percentage of people dying in hospital 2010-2012 CCGs England http://www.endoflifecare-intelligence.org.uk/profiles/ccgs/place_of_death/atlas.html

Aims To assess the variability in hospital use at the end of life and assess the influence of three sets of factors: a. The age/gender and socio economic status of patients b. The health problems presented by the patient, and the cause of death c. Features of the local health systems including common practices within individual hospital or primary care providers, and availability of alternatives to hospital care

Methods Based on all people who died over a 3 year period 2009-2012 Link hospital records at person level to identify activity in last 12 months of life Generate descriptive variables Create models to explain Admissions in last 12 months of life Bed days in last 12 months of life Whether a person died in hospital

HES as a data source Positives Inpatient records from 2001 A&E attends and Outpatient from 2005-07 Comprehensive for NHS care across the country reasonably standardised Negatives Limited clinical information Varying quality of recording esp diagnoses Focuses on acute hospital care and misses community Common person level identifier Linked to ONS death data

Cohort studied No. excluded % excluded (of all deaths) No. remaining in cohort All death records 2009/10 to 2012/13 - - 1,385,103 No hospital record in final year 132,588 9.57% 1,252,515 No gender information 8,707 0.63% 1,243,808 No residential (LSOA) information 774 0.06% 1,243,034 Resided outside England 8,008 0.58% 1,242,687 Subsequent (post death date) hospital activity 11,167 0.81% 1,223,859 Final study cohort - - 1,223,859

Impact of age on hospital use

Changes cost per day

Changes in activity during last year of life (log scale)

Independent Variables Patient characteristics Age bands 5 Sex 2 Ethnicity 10 IMD (excluding health) C Population Density C Clinical/health characteristics Diagnostic Group 145 Cause of Death 117 Number of Long Term Conditions 10 Charlson Index 22 Local health system List Size GP C Number of GP FTE C Access to care home/hospice beds C Predomionant hospital 364

Model performance Model dependent variable: Admissions Bed Days Died in hospital Mean 2.28 30.05 51.3% Standard Deviation 2.17 38.91 50.0% 10 percentile 0.00 0.00 0.0% Median 2.00 17.00 100.0% 90 percentile 5.00 75.00 100.0% Unadjusted coefficient of variation 0.949 1.295 0.975 Model performance R Squared 0.187 0.123 0.219 Adjusted coefficient of Variance 0.856 1.213 0.862

Unadjusted differences by hospital type

Adjusted differences by hospital type

Ethnicity and hospital use at end of life

Variables that explain admission to hospital in last 12 months Admissions Variable group % 'explained' Age bands 11.1% Sex 0.4% Ethnicity 4.5% IMD (excluding health) 0.1% Population Density 0.0% Clinical/health characteristics Diagnostic Group 65.0% Cause of Death 9.4% Number of Long Term Conditions 0.4% Charlson Index 0.7% Local health system List Size GP 0.0% Number of GP FTE 0.0% Access to care home/hospice beds 0.0% Predominant Hospital 8.4%

Diagnostic codes associated with greatest bed day use Bed days Description Estimate Standard Error Pr > t F04-F09 Other organic including symptomatic mental disorders 31.336 0.914 <.0001 L00-L14 L55-L99 Other infections and disorders of the skin 32.311 0.333 <.0001 L40-L45 Papulosquamous disorders (including Psoriasis) 32.348 2.889 <.0001 C81-C96 Malignant neoplasms of lymphoid, haematopoietic & rel. tiss. 32.439 0.389 <.0001 G20-G26 Extrapyramidal & movement disorders (incl. Parkinsonism). 32.509 0.757 <.0001 L50-L54 Urticaria and erythems 32.818 3.374 <.0001 N99 Other disorders of the genitourinary system 32.941 3.513 <.0001 E10-E14 Diabetes Mellitus 33.269 0.537 <.0001 G10-G13, G30-G32 Other degenerative diseases (incl. Alzheimer). 33.551 0.523 <.0001 A15-A19 Tuberculosis 34.051 1.917 <.0001 T80-T88 Complications of surgical & medical care nec. 37.581 0.412 <.0001 M95-M99 Other disorders of the musculoskeletal system & conn. tiss. 37.894 3.512 <.0001 F00-F03 Dementia 39.013 0.461 <.0001 G35-G37 Demyelinating diseases (incl Multiple Sclerosis) of the CNS. 39.665 1.615 <.0001 A00-A09 Intestinal infectious diseases 39.776 0.676 <.0001 C40-C41 Malignant neoplasm of bone and articular cartilage 40.078 1.631 <.0001 F30-F39 Mood [affective] disorders 50.080 1.019 <.0001 R69 Unknown & unspecified causes of morbidity 51.857 0.422 <.0001 F80-F99 Other mental and behavioural disorders 59.390 2.489 <.0001 F20-F29 Schizophrenia, schizotypal and delusional disorders 65.199 1.208 <.0001 F70-F79 Mental retardation 95.746 5.528 <.0001

Relationship between ACS admissions and IMD Figure 7.2 Age/Sex Adjusted ACS Admissions/1,000 by Local Authority and Area IMD

Admissions in last 12montsh of life by IMD Figure 7.3 Age/Sex Adjusted Admissions Last Year of Life by Local Authority and Area IMD

Overview Admissions Bed Days Died in Hospital Variable group % 'explained' % 'explained' % 'explained' Ethnicity 4.5% 3.4% 0.2% IMD (excluding health) 0.1% 0.2% 0.1% Clinical/health characteristics Diagnostic Group 65.0% 52.6% 57.0% Cause of Death 9.4% 13.3% 35.7% Number of Long Term Conditions 0.4% 0.1% 0.1% Charlson Index 0.7% 0.7% 2.2% Local health system Access to care home/hospice beds 0.0% 0.1% 0.0% Predominant Hospital 8.4% 28.8% 3.9%

Selected summary points Able to apply much more sophisticated adjustments for the range of factors influencing care use Provider seems to have a relatively small impact on admission and dying in hospital but much bigger impact on length of stay=> if you want to improve efficiency look at stay lengths and across more than just final episode of care Significant residual differences by ethnic group Variability in hospital use at end of life associated with deprivation much less than for ACS admissions

www.nuffieldtrust.org.uk Sign-up for our newsletter www.nuffieldtrust.org.uk/newsletter Follow us on Twitter (http://twitter.com/nuffieldtrust) Thank You